• Mutant KRAS protein bound to GTPase-activating proteins

    Frederick National Lab Launches New Partnership with Weizmann Institute of Science

    The partnership could help identify drugs to target KRAS-driven cancers. 

    Read More View All
  • The 2017 Technology Showcase held at the Frederick National Lab’s Advanced Technology and Research Facility.

    Inaugural Technology Showcase Draws Hundreds

    The event featured technologies being developed at the FNLCR and the NCI to encourage startup company formation, technology licensing, and collaborations. 

    Read More View All
  • This image represents an infection-fighting cell called a neutrophil. In this artist’s rendering, the cell’s DNA is being “edited” to help restore its ability to fight bacterial invaders. Credit: NIAID, NIH

    New Technology Shows Promise for Developing Potential Therapies for Inherited Diseases

    The targeted approach uses gene editing in animal models to research treatments for inherited diseases. 

    Read More View All
  • Electron micrograph images of human T cells. Left: A healthy T cell. Right: An HIV-infected TH9 cell.

    Antibody Therapy Could Be an Effective Method for HIV-1 Prevention

    FNL researchers are part of four recent studies that have helped scientists better understand HIV.

    Read More View All

  • Frederick National Lab Rallies to Meet Demand for Zika Vaccine

    The Vaccine Pilot Plant is helping researchers produce investigational Zika vaccines for a new round of clinical trials.

    Read More View All
Who We Are Discovery, innovation, and success in the biomedical sciences. Learn More

The Frederick National Lab is dedicated to improving human health through discovery and innovation in the biomedical sciences. The lab has a sharp focus on cancer, AIDS, and infectious disease.